Document:

Exhibit 10.2

 

 

  

August 8, 2018

  

Steve O’Loughlin

317 21st Street

Union City, NJ 07087

  

Dear Mr. O’Loughlin,

 

On behalf of Actinium
Pharmaceuticals, Inc. (the “Company”), I am pleased to provide you with this contract related to your position
as Principal Financial Officer of the Company. This agreement (the “Agreement”) amends and restates your September
17, 2015 Employment Agreement (“Prior Agreement”). This Agreement sets forth the terms related to your position as
Principal Financial Officer of the Company while retaining and adapting material provisions of the Prior Agreement to that of your
role of Principal Financial Officer.

 

1. Position. The terms of your new
position with the Company are as set forth below:

 

(a) You shall serve as
Principal Financial Officer.

 

You shall report to the
Chief Executive Officer or designee and shall perform your duties for the Company at the Company’s offices except for travel
that may be necessary or appropriate in connection with the performance of your duties hereunder. The offices of the Company are
currently located in New York City at 275 Madison Avenue, 7th Floor, New York, NY 10016.

 

(b) You agree to devote
your best efforts and substantially all of your business time to advance the interests of the Company and to discharge adequately
your duties hereunder. You may perform certain consulting projects that do not interfere with your Company duties and maintain
whatever licenses required for performance of such consulting activities. Consulting activities must be non-competitive with the
Company’s plans, disclosed and approved on a case by case basis by your direct supervisor or an authorized Company representative.

 

2. Effective Date.
The effective date of this Agreement is August 8, 2018.

 

     

     

    

 

3. Proof of Right
to Work. For purposes of federal immigration law, you provided to the Company documentary evidence of your identity and eligibility
for employment in the United States.

 

4. Compensation.

 

(a) Base Salary. The
Board shall review the amount of your base salary and performance bonus, and shall determine the appropriate adjustments to each
component of your compensation each calendar year.

 

(b) Performance Bonus.
You shall be entitled to participate in an executive bonus program, which shall be established by the Board pursuant to which the
Board may award bonuses of up to 30% to you, based upon the achievement of written individual and corporate objectives such as
the Board shall determine.

 

(c) Stock Option Grant.
From time to time the Board may grant you an options to purchase common shares of the Company (the “Grant”).
The Grants shall be subject to the vesting schedule below.

 

(i) Stock Options.
Such options will have an exercise price equal to the closing price of the Company’s common stock on the grant date (the
“Grant Date”).

 

(ii) Vesting Schedule. Two percent (2%) of such options shall
vest each month after the date of grant until fully vested. The term of all options granted under this Agreement will be for 10
years from the date of grant, subject to your continuing service with the Company. The options or restricted stock will be incentive
stock options or stock to the maximum extent allowed by the tax code and will be subject to the terms of the Company’s Amended
and Restated 2014 Stock Plan and the Stock Option Agreement between you and the Company.

 

5. Benefits.

 

a. Benefit plan –
Health Insurance, Retirement and Stock Option Plan. The Company will provide you with the opportunity to participate in the
standard benefits plans currently available to other similarly situated employees. The Company reserves the right to cancel and/or
change the benefits plans it offers to its employees at any time, subject to applicable law.

 

b. Vacation;
Sick Leave. You will be entitled to 20  days paid vacation per year, pro-rated for the remainder of this calendar year.
Vacation may not be taken before it is accrued. You will be entitled to 5 days paid sick leave per year pro-rated.

 

c. Other Benefits.
The Company will provide you with standard business reimbursements (including mileage, supplies, long distance calls), subject
to Company policies and procedures and with appropriate receipts. In addition, you will receive any other statutory benefits required
by law.

 

    	 	2	 

     

    

 

d. Reimbursement of
Expenses. You shall be reimbursed for all normal items of travel and entertainment and miscellaneous expenses reasonably incurred
by you on behalf of the Company provided such expenses are documented and submitted in accordance with the reimbursement policies
in effect from time to time.

 

6. Confidential
Information and Invention Assignment Agreement. You have already executed the Company’s Confidential Information and
Invention Assignment Agreement, (the “Confidentiality Agreement”), which remains in effect.

 

7. At-Will Employment.
Your employment with the Company will be on an “at will” basis, meaning that either you or the Company may terminate
your employment at any time for any reason or no reason, without further obligation or liability.

 

8. Non-Solicitation.
You agree that during the term of your employment with the Company, and for a period of 24 months following the cessation of employment
with the Company for any reason or no reason, you shall not directly or indirectly solicit, induce, recruit or encourage any of
the Company’s employees or consultants to terminate their relationship with the Company, or attempt any of the foregoing,
either for yourself or any other person or entity. For a period of 24 months following cessation of employment with the Company
for any reason or no reason, you shall not attempt to negatively influence any of the Company’s clients or customers from
purchasing Company products or services or to solicit or influence or attempt to influence any client, customer or other person
either directly or indirectly, to direct his or its purchase of products and/or services to any person, firm, corporation, institution
or other entity in competition with the business of the Company.

 

9. Arbitration.
Any dispute or claim arising out of or in connection with your employment with the Company (except with regard to enforcement of
the Confidentiality Agreement) will be finally settled by arbitration in New York, New York in accordance with the Commercial Arbitration
Rules of the American Arbitration Association by one arbitrator appointed in accordance with said rules. Judgment on the award
rendered by the arbitrator may be entered in any court having jurisdiction thereof. The parties agree that this Agreement evidences
a transaction involving interstate commerce and that the operation, interpretation and enforcement of this arbitration provision,
the procedures to be used in conducting an arbitration pursuant to this arbitration provision, and the confirmation of any award
issued to either party by reason of such arbitration, is governed exclusively by the Federal Arbitration Act, 9 U.S.C. § 21
et seq. Notwithstanding the foregoing, the parties may apply to any court of competent jurisdiction for preliminary or interim
equitable relief, or to compel arbitration in accordance with this paragraph, without breach of this arbitration provision.

 

    	 	3	 

     

    

 

10. Miscellaneous.
This Agreement, together with the Confidentiality Agreement, sets forth the terms of your employment with the Company and supersedes
any prior representations or agreements, whether written or oral. This Agreement may not be modified or amended except by a written
agreement, signed by the Company and by you. Whenever possible, each provision of this Agreement will be interpreted in such manner
as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable
in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will be lessened
or reduced to the extent possible or will be severed and will not affect any other provision and this Agreement will be reformed,
construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein.
This Agreement will be governed by New York law without reference to rules of conflicts of law. All notices, requests, demands
and other communications called for hereunder shall be in writing and shall be deemed given (i) on the date of delivery if delivered
personally, (ii) one (1) day after being sent by a well established commercial overnight service, (iii) three (3) days after being
mailed by registered or certified mail, return receipt requested, prepaid and addressed to the parties or their successors at the
following addresses, or at such other addresses as the parties may later designate in writing, (iv) upon confirmation of facsimile
transfer, if sent by facsimile or (v) upon confirmation of delivery when directed to the electronic mail address set forth below,
if sent by electronic mail:

 

	 	If to the Company:	275 Madison Avenue, Suite 702
	 	 	New York, NY 10016
	 	 	 
	 	If to you:	Steve O’Loughlin
	 	 	317 21st Street
	 	 	Union City, NJ 07087

 

We are all delighted
to be able to extend you this offer and look forward to working with you. To indicate your acceptance of the Company’s offer,
please sign and date this letter in the space provided below and return it to me, along with a signed and dated copy of the Confidentiality
Agreement.

  

(signature page follows)

 

    	 	4	 

     

    

 

	Very truly yours,	 	ACCEPTED AND AGREED:
	 	 	 
	ACTINIUM PHARMACEUTICALS, INC.	 	STEVE O’LOUGHLIN
	 	 	 
	By:	/s/ Sandesh Seth	 	/s/ Steve O’Loughlin
	 	                                	 	Signature
	Title:	Chief Executive Officer	 	

  

    	 	5ex_120074.htm

Exhibit 10.1

 

AMENDMENT NO. 3

TO THE

CATHAY BANK

EMPLOYEE STOCK OWNERSHIP PLAN

 

 

 

Cathay General Bancorp (the "Company") hereby amends the above-named plan (the "Plan"), effective as of January 1, 2016, as follows:

 

1.     Subsection (iv) of Section 6.2(a) of the Plan is hereby amended in its entirety to read as follows:

 

"(iv)     Despite any other provision of the Plan, the benefits in the Participant's Stock Account that consist of Stock in an S Corporation shall be distributed in the form of cash. Any benefits in the Participant's Stock Account that do not consist of Stock in an S Corporation shall also be distributed in the form of cash, unless such Participant elects to receive his or her benefits in the form of Stock."

 

* * * * * * * *

 

The Company has caused this Amendment No. 3 to be signed on the date indicated below, to be effective as indicated above.

 

	
			 

				
			"Company"

				
			 

			
	 	 	 
	 	CATHAY GENERAL BANCORP	 
	 	 	 
	
			 

				
			 

				
			 

				
			 

			
	
			 

				
			 

				
			 

				
			 

			
	
			Dated:

				 June 21, 2018	 	
			By: 

				
			 /s/ Pin Tai 

				
			 

			
	
			 

				
			 

				
			 

				
			 

			
	
			 

				
			Its:

				
			 CEO and President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00286-of-00352.parquet"}]]